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From 1995 to 1998, outbreaks of bubonic plague occurred
annually in the coastal city of Mahajanga, Madagascar. A total
of 1,702 clinically suspected cases of bubonic plague were
reported, including 515 laboratory confirmed by Yersinia pestis
isolation (297), enzyme-linked immunosorbent assay, or both.
Incidence was higher in males and young persons. Most
buboes were inguinal, but children had a higher frequency of
cervical or axillary buboes. Among laboratory-confirmed hospi-
talized patients, the case-fatality rate was 7.9%, although all Y.
pestis isolates were sensitive to streptomycin, the recom-
mended antibiotic. In this tropical city, plague outbreaks occur
during the dry and cool season. Most cases are concentrated in
the same crowded and insanitary districts, a result of close con-
tact among humans, rats, and shrews. Plague remains an
important public health problem in Madagascar, and the poten-
tial is substantial for spread to other coastal cities and abroad.
lague is enzootic in the central highlands of Madagascar,
where approximately 200 to 400 bacteriologically con-
firmed or presumptive cases are reported each year to the
World Health Organization; 1,500 to 2,500 clinically sus-
pected cases are reported by the national surveillance system
(1,2). In this island, the main reservoir of Yersini. pestis is the
black rat (Rattus rattus) and the main vector the rat flea
(Xenopsylla cheopis) (3). From the arrival of plague in Mada-
gascar in 1898 until the 1920s, plague occurred in several har-
bors around the island. It disappeared progressively from the
coastal areas as soon as it reached the central highlands where,
above an altitude of about 800 m, it found a suitable environ-
ment. A period of quiescence in the coastal areas lasted more
than 60 years. Then, in August 1991, a sudden outbreak lasting
7 months occurred in the harbor of Mahajanga (4). During the
next 3 years, when neither an epizootic nor a human case was
reported, the outbreak was considered an isolated epidemio-
logic incident. However, in 1995 a new epidemic occurred
(5,6), which was followed by three others, in 1996, 1997, and
1998. These outbreaks accounted for approximately 30% of
the reported cases of plague in Madagascar during the period.
We describe the main epidemiologic features of these four
urban outbreaks in this exceptional resurgent coastal plague
focus.
Population and Methods
In Madagascar, health workers must report all clinically
suspected cases of plague to the national surveillance system.
For each patient, a biological sample (bubo aspirate, sputum,
or postmortem liver or lung puncture, whenever appropriate)
has to be collected and sent by mail to the National Reference
Laboratory at the Institut Pasteur de Madagascar in the capital,
Antananarivo. The delivery time is frequently 2-3 weeks after
the specimen was collected, and the only reliable method to
allow bacteriologic diagnosis remains bubo aspiration (as well
as sputum and postmortem liver or lung puncture, whenever
appropriate) and transportation on a swab in Cary-Blair
medium. Blood samples for culture were not adopted in Mada-
gascar since the likelihood of isolating Y. pestis is approxi-
mately twice as high in buboes as in blood. In August and
September 1997, a temporary bacteriology laboratory was
established in Mahajanga; thus, all the biological samples col-
lected during these 2 months were processed on site.
The confirmatory diagnosis was based on bacteriologic
methods. A case of plague was considered to be confirmed as
soon as a strain of Y pestis was isolated by culture or mouse
inoculation. A patient was considered to have a presumptive
plague case when Y. pestis could not be isolated but gram-neg-
ative bacillus, with morphologic patterns of Y. pesti, could be
detected on smear. Microscopy lacks both sensitivity and spec-
ificity, and the isolation of Y. pestis requires at least 6 days.
Prior treatment of patients with antibiotics impedes the culture
and may lead to false-negative results. Physicians were asked
to collect an acute-phase serum sample before treatment and a
convalescent-phase serum sample at least 7 days after the
onset of disease. Whenever available, the sera and bubo aspi-
rates were tested for F1-antigen by immunocapture enzyme-
linked immunosorbent assay (ELISA) (7,8) and for anti-F1
antibodies by the classical indirect ELISA method (9).
In this study, the bacteriologically confirmed or presump-
tive patients, the ELISA-positive patients (F1 antigen or anti-
bodies), or both were defined as having laboratory-confirmed
cases. Clinical and epidemiologic data were collected on stan-
dard forms, after the patients or their families were inter-
viewed. Reporting to the national surveillance system was
assumed to be thorough, as confirmed by a seroepidemiologic
survey in 1999 (10). In Madagascar all Y. pestis isolates are
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screened for their in-vitro resistance to streptomycin, gentami-
cin, chloramphenicol, tetracycline, sulfamethoxazole-trime-
thoprim, and ampicillin.
The geographic distribution of plague patients was visual-
ized by using a simplified map of Mahajanga. For this purpose,
the city was divided into four areas. We defined the boundaries
of these areas by aggregating districts that were comparable for
population density, sanitation level, and housing type.
Results
In 1995, the first identified case occurred in March, fol-
lowed by several sporadic cases in May and July. The outbreak
proper started by mid-August. From 1995 to 1998, 1,702 clini-
cally suspected bubonic plague cases were reported; 335 were
considered confirmed (297) or presumptive (38) cases after
bacteriologic testing. None of the Y. pestis isolates was recov-
ered from sputum. When either F1 antigen capture or anti-F1
ELISA assays were used, 180 more cases were laboratory con-
firmed. In all, 515 persons were considered to have contracted
plague from January 1, 1995, to December 31, 1998.
For each of the 4 years we studied, a biological result was
available for 88.5%, 98.7%, 97.2%, and 99.5% of the sus-
pected patients, respectively. When bacteriologic methods
were used, the annual confirmation rates were 22.2%, 14.8%,
30.1%, and 30.3%, respectively. The proportions represented
by bacteriologically confirmed cases among the total number
of laboratory-confirmed patients were 72.3%, 83.6%, 98.7%,
and 88.1%, respectively. Detailed laboratory results are sum-
marized in the Table.
Two of the 297 Y. pestis isolates from Mahajanga patients
were resistant to one of the tested antibiotics, one to chloram-
phenicol in 1996 and one to ampicillin in 1998.
The proportion of males (56.1%) was significantly higher
among cases than in the general population (p=0.006). The age
and sex-distribution of patients with laboratory-confirmed
cases remained unchanged during the 4 years (Figure 1). The
median age of patients was 15 years, and 75% of patients were
<25 years old. Although the highest incidence of the disease
was observed in 5-to 19-year-old persons, 59 cases occurred in
children <5 years old; 2 were <1 year old.
Among laboratory-confirmed cases, a significantly higher
frequency of cervical and axillary buboes occurred in children;
by contrast, inguinal buboes represented about 80% of cases in
persons ≥ 20 years of age (p<10-7). The distribution of bubo
location according to age is shown in Figure 2. Body tempera-
tures were available for 454 of persons with laboratory-con-
firmed cases: the median temperature was 39.5°C (25th and
75th percentiles were 38.2°C and 40°C). Diarrhea (7.1%),
prostration (4.5%), and coma (1%) were the other most fre-
quently reported symptoms.
A total of 507 laboratory-confirmed patients were admitted
to hospital; 40 (7.9%) of them died. The case-fatality rate was
not significantly different by year (7.1%, 9.3%, 6.7%, and
10.3% in 1995, 1996, 1997, and 1998, respectively). Nor was
this rate related to age, sex, bubo location, or delay between
onset of disease (as reported by the patients) and initiation of
treatment. Lethality was also not correlated with drug suscep-
tibility of Y. pestis isolates, since they were all sensitive to
streptomycin, the drug recommended by the national program.
Only the body temperature at admission to the hospital was
significantly higher in the group of deceased patients than in
recovered (39.6°C vs. 39.1°C, p=0.01).
Table. Results of bacteriology testing for Yersinia pestis, Mahajanga, 
Madagascar, by year
1995 1996 1997 1998 Total
Total suspected cases 558 399 539 206 1,702
Laboratory-confirmeda 
cases
117 97 214 87 515
Bacteriology
Number tested 342 330 501 195 1,368
Number confirmed 55 41 149 52 297
Number presumptive 21 8 2 7 38
Number positiveb 76 49 151 59 335
Percent positive 22.2 14.8 30.1 30.3 24.5
F1 antigen ELISA
Number tested 433 335 413 189 1,370
Number positive 38 25 131 35 229
Percent positive 8.8 7.5 31.7 18.5 16.7
Anti-F1 antibodies ELISA
Number tested 365 344 396 191 1,296
Number positive 68 59 137 48 312
Percent positive 18.6 17.2 34.6 25.1 24.1
aConfirmed + presumptive and/or enzyme-linked immunosorbent-assay
 (ELISA) positive.
bConfirmed + presumptive cases
Figure 1. Age and sex-distribution of laboratory-confirmed bubonic
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Most (76%) patients were reported during August through
October during the dry season, a peak that occurs every year.
The temperature patterns in Mahajanga and the monthly distri-
bution of laboratory-confirmed cases are related. The out-
breaks used to occur in July, when the temperature is the
lowest of the year, and ceased in November, when the temper-
ature rebounds (Figure 3).
Among the 357 laboratory-confirmed plague patients for
whom data were available about rat deaths within the 15 days
preceding onset of disease, 203 (56.9%) had found dead rats
indoors or in the vicinity of their homes; 154 (43.1%) had not
noticed dead rats in their surroundings. Of the 203 who had,
117 (57.6%) had found the dead rats inside their homes. The
confirmation rate was higher among persons who reported rat
deaths in their surroundings than among persons not reporting
such deaths (57.7% versus 24.6%, p<10-7).
The geographic distribution of plague laboratory-con-
firmed cases according to districts is shown in Figure 4. The
residence of patients could be clearly identified on this map for
473 (91.8%) of the laboratory-confirmed cases. The incidence
of plague differed sharply according to districts: most patients
(82.9%) lived in Area 1, which pools the most unhealthy and
densely populated districts of the town. The southwestern part
of the city (Area 2), including the harbor and the old colonial
town, had few cases and did not show any trend towards
increasing incidence. Areas 3 and 4, greener and less populous
suburbs of Mahajanga, showed an intermediate incidence. The
increase in cases in 1997, especially in Area 3, was no longer
occurring in 1998.
Discussion
World plague foci are mostly restricted to temperate cli-
mate highlands such as regions in East Africa, central Asia,
and the American Southwest; outbreaks in coastal areas have
become rare. Thus, the situation in the harbor of Mahajanga,
where plague has found favorable conditions and seems to
have established itself, is noteworthy. During 4 successive
years, 97 to 214 laboratory-confirmed plague cases were
reported annually, raising questions about epidemiologic
determinants of this disease’s having taken roots in this tropi-
cal city. Before its sudden reemergence in 1991 after more
than 60 years of quiescence, plague in Madagascar was sup-
posedly restricted to areas above 800 m because of climatic
constraints that influence the proliferation of fleas and Y. pestis
(11). In Mahajanga, as had already been observed in 1907
(12), the plague season starts in July or August, during the dry
season, when the air temperature is the lowest. This is in con-
trast with the central highlands, where most of the cases occur
between October and February, during the warmer rainy sea-
son (2). Indeed, during the plague season for both the coastal
and plateau regions, the minimum temperature is about the
same, between 17° and 22°C. Recent studies have shown that
the plague season in the central highlands is clearly linked to
the abundance both of fleas and the black rat, R. rattus, the
main reservoir and virtually the only small mammal found in
houses (95% of captures in traps) (13). In Mahajanga, ongoing
studies have shown that the Asiatic shrew, Suncus murinus,
accounts for up to 75 % of the trapped animals and is a regular
carrier of the rat flea, X. cheopis (Duplantier et al., unpub.
data). Moreover, the seroprevalence among shrews trapped
during the postepidemic period was 43% in 1995. Y. pestis
strains were also isolated from five shrews in 1996 and 1997
(Chanteau et al., unpub. data ). All these findings strongly sug-
gest the determinant role of shrews as a previously
Figure 2. Distribution of bubo location according to age in laboratory-
confirmed bubonic plague cases, Mahajanga, Madagascar.
Figure 3. Mean air temperatures and month-distribution of laboratory-
confirmed cases of bubonic plague, Mahajanga, Madagascar,  since
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unrecognized host of Y. pestis in the epidemiologic cycle of
plague in Mahajanga. This new parameter complicates and
revises the classical rodent-flea-human triad. In Southeast
Asia, the role of S. murinus in plague is established (14,15).
The epidemic wave of plague that started in August 1991
and lasted until February 1992 was confined to the neighbor-
hood surrounding the main market in Area 1; this region, and
more precisely a place named Marolaka, was considered to be
the epicenter of the outbreak (4). The source of the initial con-
tamination was probably inland, due to the trading of agricul-
tural products from the northern plague foci to the
marketplace, as suggested by results of the Y. pestis genotyp-
ing by pulsed-field gel electrophoresis (Buchrieser et al.,
manuscript in preparation). Although we think that an inland
reintroduction of the infection is unlikely to occur for 4 con-
secutive years under the same pattern, we cannot exclude this
hypothesis until molecular analysis of the isolates is available.
The epidemic ring did not extend to the other areas of the
town, and this quiescence lasted 3 years, during which infor-
mation about hosts and fleas was scarce. The starting point for
the second epidemic wave described here was in exactly the
same zone of the marketplace; however, this time, the plague
front extended to the other three areas. Over the 4 years, the
incidence was higher in Area 1 than in the others, although in
1997 Area 3 was clearly affected. The plague front did not
extend further than 10 to 15 km from town.
A geomedical survey (Rakotoarisoa S, unpub. data) con-
cluded that three different types of structures were present in
the entire city of Mahajanga. Area 2 is almost comparable with
a European city with its wide, paved streets, sewer network,
store buildings with apartments in the upper floors, and low
population density); Areas 3 and 4 are semirural suburbs with
low population density. In contrast, Area 1, which was the epi-
center for the two waves of the outbreak, is densely populated
with very poor people. This area also includes the two largest
markets, which generate the town’s largest amount of rubbish.
Therefore, while no physical barrier separates Area 1 from
Area 2, the lower incidence in the latter could be related to the
slimmer chance of contact between humans and reservoirs of
plague, in short, to better housing conditions. 
Clinically, despite some published claims that the clinical
diagnosis of bubonic plague is straightforward, field data show
a bacteriologic confirmation rate no greater than 30% for the
best years. This rate improved in 1997 and 1998, compared
with 1995 and 1996, suggesting that physicians are becoming
more skilled at making this diagnosis. The increased confirma-
tion rate was also due to their increased skill in collecting bubo
pus and the progressive shortening of the delay before the
samples were analyzed in a laboratory. Except during the 2
months of August and September 1997, bubo samples arrived
at the central plague laboratory in Antananarivo as long as 2 or
3 weeks after being collected, which led to false-negative
results because they were contaminated or the plague bacillus
had died. The use of ELISA methods to detect either F1 anti-
gen in acute-phase bubo samples or antibodies in convales-
cent-phase serum contributed to the confirmation of 35% of
the total laboratory-confirmed cases. However, bacteriology
and ELISAs are used as retrospective tools to confirm plague.
Only a rapid diagnostic test such as the F1 dipstick assay is a
valuable tool for health workers (8).
The higher incidence of bubonic plague in males than
females and in young persons rather than in adults is a constant
epidemiologic feature in Madagascar, whether in Mahajanga
or the highlands (1-3). In published studies, gender differences
in incidence rates differ by country (16). In India, females
were more frequently infected; in the city of Hai-nan, China,
males and females were equally affected; and in Manchuria,
the situation was similar to that in Madagascar (16). Despite
its being well accepted that incidence is linked to extrinsic
more than intrinsic factors, we could not find any link to occu-
pational behavior. 
The effects of human age on the relationship between rat
fleas and people and of gender on this disease deserve further
study. The observation of a relationship between the age and
the bubo location is common in Madagascar, although it has
not been described elsewhere. As it is widely accepted that the
location of the bubo is dependent on the place where the injec-
tion of Y. pestis occurred, we infer that infective flea bites
more often involve the upper extremities in children than in
adults. In the urban plague focus of Mahajanga, as in the cen-
tral highlands, transmission is believed to occur mostly inside
houses. Although we do not have any indications that children
have specific risks, such as handling dead rodents in play, chil-
dren do spend more time close to the floor (e.g., games, sleep-
ing) than adults) and therefore are closer to fleas.
From the start, the absence of pneumonic plague has been
remarkable. The natural course of bubonic plague can lead to
secondary pneumonic plague, which can give rise to highly
Figure 4. Incidence of laboratory-confirmed bubonic plague cases
according to the patients’ place of residence, in Mahajanga, Madagas-
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contagious cases of primary pneumonic plague in contacts, as
seen every year in the highlands of Madagascar (17). Yet not a
single contact case has been reported, even though several
bubonic patients died before being diagnosed and treated and
thus contacts remained unidentified who could have benefited
from chemoprophylaxis. This observation fits with early stud-
ies describing peumonic plague only in temperate places. As
far back as 1929, Thiroux pointed out that pneumonic plague
outbreaks had never been observed in Madagascar in areas
where the absolute minimum temperatures did not remain reg-
ularly under 16°C for several consecutive days (18). As early
as 1907, in the absence of effective treatment and chemopro-
phylaxis, only four cases of pneumonic plague had been
observed among 72 plague cases during the first epidemic in
Mahajanga. The absence of lung infection apparently is not
related to a particular strain of the plague bacillus since the Y.
pestis strain that currently circulates in Mahajanga was likely
introduced from the highlands in 1991, as demonstrated by
pulsed-field gel electrophoresis genotyping (Buchrieser et al,
manuscript in preparation).
The case-fatality rate is somewhat higher than reported in
published studies, and it does not show any trend towards
decreasing. However, we considered only laboratory-con-
firmed cases, and technical conditions in Mahajanga hospital
are poor. We believe that a major proportion of treatment fail-
ures could be avoided if patients did not wait 2 days or more
before coming to hospital. Moreover, dates of onset seem to be
questionable for some serious cases; apparently families are
often reluctant to imply that they have been negligent in man-
aging the patient at home, or they have resorted to traditional
healing before referring the patient to a hospital. Up to now,
antibiotics used to treat the disease (streptomycin is the recom-
mended treatment in Madagascar) have been totally effective
against Y. pestis strains from Mahajanga. The discovery of one
chloramphenicol-resistant isolate and one ampicillin-resistant
isolate requires that the country maintain an efficient bacteriol-
ogy surveillance system. The appearance and spread of multi-
resistant Y. pestis strains, such as the two isolated in 1995 in
the highlands, are cause for concern (19,20).
Plague is still a threat in Madagascar and is no longer
restricted to areas in the highlands over 800 m. A bubonic
plague outbreak has been reported recently at 500 m altitude
(21,22). Such epidemics as we describe may occur in any other
coastal city where the shrew S. murinus and the flea X. cheopis
are present. Because trade between the highlands and the ports
has intensified, an active program for surveillance and moni-
toring of plague borders must be maintained. Improved ways
to rat-proof structures should also be encouraged.
Dr. Boisier is a physician and specialist in epidemiology, working
for the French Army Health Service. His research interests include
the epidemiology and control of tropical diseases. 
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